SYBX · XBRL financial data

Synlogic financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (SYBX's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	393	year only	8	0	0	0*	0	0	0	0*	0	0
Research and development	9,616	10,140*	7,680	2,197	—	year only	22	—	—	year only	49	—
General and administrative	3,400	3,270*	2,884	1,179	1,165	1,403*	836	800	818	1,035*	1,064	828
Total operating expenses	13,016	13,410*	38,853	(419)	748	1,776*	898	777	991	1,342*	1,319	1,012
Operating income (loss)	(12,623)	(10,641)*	(38,845)	419	(748)	(1,776)*	(898)	(777)	(991)	(1,342)*	(1,319)	(1,012)
Interest expense	0	0*	0	0	0	0*	—	—	—	—	—	—
Other income (expense)	(1)	(508)*	(2)	0	1	(1)*	0	0	0	0*	—	—
Income tax expense (benefit)	3	2*	—	5	0	0*	—	0	0	0*	—	—
Net income (loss)	(12,078)	(14,534)*	(31,564)	2,012	(117)	(714)*	317	(529)	(2,301)	1,508*	681	(543)
Earnings per share, basic USD per share	(2.57)	—	(2.60)	0.16	(0.01)	—	0.03	(0.04)	(0.19)	0.12*	0.05	(0.04)
Earnings per share, diluted USD per share	(2.57)	—	(2.60)	0.16	(0.01)	—	0.03	(0.04)	(0.19)	0.12*	0.05	(0.04)
Weighted average shares, basic thousands of shares	4,700	—	12,131	12,204	12,224	12,225*	12,284	12,319	12,319	12,325*	12,395	12,419
Weighted average shares, diluted thousands of shares	4,700	—	12,131	12,399	12,224	12,032*	12,389	12,319	12,319	12,222*	12,399	12,419

Balance sheet

CSV

Fiscal quarters (SYBX's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	24,536	23,960	24,822	19,966	19,389	18,860	17,271	17,027	15,591	14,668	14,105	13,183
Marketable securities	8,879	23,786	7,489	0	0	0	—	—	—	—	—	—
Prepaid and other current assets	4,365	2,161	2,429	1,491	1,230	830	559	293	914	729	456	245
Total current assets	37,780	49,907	34,946	21,573	20,705	19,776	17,916	17,320	16,505	15,397	14,561	13,428
Property and equipment, net	5,949	5,603	0	0	0	0	—	—	—	—	—	—
Right-of-use asset	12,827	12,102	0	0	0	0	—	—	—	—	—	—
Total assets	66,254	75,550	36,057	21,635	20,755	19,826	17,966	17,370	16,555	15,447	14,611	13,478
Accounts payable	708	1,457	719	126	178	164	80	45	107	103	206	80
Accrued liabilities	3,679	3,000	3,116	2,297	1,756	2,037	946	952	858	915	1,157	1,036
Total current liabilities	9,144	20,404	10,940	5,652	7,647	7,075	4,873	4,777	6,230	3,584	2,057	1,461
Lease liability, non-current	13,706	12,491	11,792	0	0	0	—	—	—	—	—	—
Accumulated deficit	(399,767)	(414,301)	(445,865)	(443,853)	(440,937)	(441,651)	(441,334)	(441,863)	(444,164)	(442,656)	(441,975)	(442,518)
Total stockholders' equity	43,404	42,655	13,325	15,983	13,108	12,751	13,093	12,593	10,325	11,863	12,554	12,017
Total liabilities and equity	66,254	75,550	36,057	21,635	20,755	19,826	17,966	17,370	16,555	15,447	14,611	13,478
Common shares outstanding (cover page) thousands of shares	9,189	11,647	11,707	11,696	11,696	11,696	11,696	11,699	11,699	11,699	11,697	12,249

Cash flows

CSV

Fiscal quarters (SYBX's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(12,078)	(14,534)*	(31,564)	2,012	(117)	(714)*	317	(529)	(2,301)	1,508*	681	(543)
Stock-based compensation	640	803*	2,221	498	102	348*	25	29	33	30*	10	6
Net cash from operating activities	(12,955)*	(5,528)*	(15,436)	(15,005)*	(649)*	(568)*	(1,601)	(399)*	(1,436)*	(923)*	(563)	(922)*
Purchases of property and equipment	0*	28*	395	(381)*	0*	0*	0	0*	0*	0*	—	—
Net cash from investing activities	(8,832)*	(14,628)*	16,282	8,955*	72*	30*	12	155*	0*	0*	0	0*
Net cash from financing activities	62*	19,580*	16	147*	0*	9*	0	0*	0*	0*	—	—
Net change in cash	(21,725)*	(576)*	862	(5,903)*	(577)*	(529)*	(1,589)	(244)*	(1,436)*	(923)*	(563)	(922)*

Compare with peers

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Synlogic	13,183	0	(922)*	12.2M	14.3 quarters	Q2 FY26 10-QJun 30, 2026
Matinas BioPharma Holdings	761	not reported	(1,836)*	14.7M	0.4 quarters	Q2 FY26 10-QJun 30, 2026
China Pharma Holdings	305	948	(33)*	43.0M	9.3 quarters	Q2 FY26 10-QJun 30, 2026
Soligenix	9,811	not reported	(1,707)*	21.8M	5.7 quarters	Q2 FY26 10-QJun 30, 2026
Target Group	14	1,381	(223)*	617.0M	0.1 quarters	Q2 FY26 10-QJun 30, 2026
Creative Medical Technology Holdings	8,714	0	(1,472)*	6.6M	5.9 quarters	Q2 FY26 10-QJun 30, 2026
Aspira Women's Health	477	17	(2,010)*	46.6M	0.2 quarters	Q2 FY26 10-QJun 30, 2026
Healthy Extracts	190	2,067	306*	14.7M	—	Q2 FY26 10-QJun 30, 2026
Viskase Holdings	7,911	90,131	(11,205)*	14.3M	0.7 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.